Stock Scorecard
Stock Summary for Resmed Inc (RMD) - $252.53 as of 2/25/2026 10:05:54 PM EST
Total Score
20 out of 30
Safety Score
65 out of 100
Currently on the following lists
Dividend Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for RMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RMD (65 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 6 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RMD
Financial Details for RMD
Company Overview |
|
|---|---|
| Ticker | RMD |
| Company Name | Resmed Inc |
| Country | USA |
| Description | ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/23/2026 |
Stock Price History |
|
| Last Day Price | 252.53 |
| Price 4 Years Ago | 201.89 |
| Last Day Price Updated | 2/25/2026 10:05:54 PM EST |
| Last Day Volume | 667,860 |
| Average Daily Volume | 1,201,335 |
| 52-Week High | 292.44 |
| 52-Week Low | 198.14 |
| Last Price to 52 Week Low | 27.45% |
Valuation Measures |
|
| Trailing PE | 25.77 |
| Industry PE | 1,078.31 |
| Sector PE | 154.16 |
| 5-Year Average PE | 32.80 |
| Free Cash Flow Ratio | 25.95 |
| Industry Free Cash Flow Ratio | 18.07 |
| Sector Free Cash Flow Ratio | 27.01 |
| Current Ratio Most Recent Quarter | 3.06 |
| Total Cash Per Share | 9.73 |
| Book Value Per Share Most Recent Quarter | 43.39 |
| Price to Book Ratio | 6.77 |
| Industry Price to Book Ratio | 3.36 |
| Sector Price to Book Ratio | 55.05 |
| Price to Sales Ratio Twelve Trailing Months | 7.05 |
| Industry Price to Sales Ratio Twelve Trailing Months | 87.01 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.71 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 145,678,000 |
| Market Capitalization | 36,788,065,340 |
| Institutional Ownership | 67.95% |
Dividends |
|
| Ex-Dividend Date | 2/12/2026 |
| Previous Dividend Amount | 0.6000 |
| Current Dividend Amount | 0.6000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 2.33 |
| Trailing Annual Dividend Yield | 0.89% |
| Forward Annual Dividend Rate | 2.40 |
| Forward Annual Dividend Yield | 0.92% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.94% |
| 5-Year Average Dividend Yield | 0.94% |
| 1-Year Dividend Growth Rate Percentage | 6.19% |
| 3-Year Dividend Growth Rate Percentage | 3.05% |
| 5-Year Dividend Growth Rate Percentage | 8.69% |
| All-Time Dividend Growth Rate Percentage | 8.60% |
| Dividend Payout Ratio | 23.05% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 14.50% |
| Annual Earnings Growth | 37.20% |
| Reported EPS 12 Trailing Months | 10.12 |
| Reported EPS Past Year | 5.36 |
| Reported EPS Prior Year | 9.55 |
| Net Income Twelve Trailing Months | 1,485,875,000 |
| Net Income Past Year | 1,400,723,000 |
| Net Income Prior Year | 1,020,951,000 |
| Quarterly Revenue Growth YOY | 11.00% |
| 5-Year Revenue Growth | 11.72% |
| Operating Margin Twelve Trailing Months | 35.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,417,069,000 |
| Total Cash Past Year | 1,209,450,000 |
| Total Cash Prior Year | 238,361,000 |
| Net Cash Position Most Recent Quarter | 1,013,146,000 |
| Net Cash Position Past Year | 551,058,000 |
| Long Term Debt Past Year | 658,392,000 |
| Long Term Debt Prior Year | 697,313,000 |
| Total Debt Most Recent Quarter | 403,923,000 |
| Equity to Debt Ratio Past Year | 0.90 |
| Equity to Debt Ratio Most Recent Quarter | 0.94 |
| Total Stockholder Equity Past Year | 5,967,859,000 |
| Total Stockholder Equity Prior Year | 4,864,043,000 |
| Total Stockholder Equity Most Recent Quarter | 6,320,879,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,788,616,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 12.28 |
| Free Cash Flow Past Year | 1,661,723,000 |
| Free Cash Flow Prior Year | 1,286,404,000 |
Options |
|
| Put/Call Ratio | 0.51 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.03 |
| MACD Signal | 1.93 |
| 20-Day Bollinger Lower Band | 237.94 |
| 20-Day Bollinger Middle Band | 253.96 |
| 20-Day Bollinger Upper Band | 269.99 |
| Beta | 0.88 |
| RSI | 51.37 |
| 50-Day SMA | 251.49 |
| 150-Day SMA | 217.63 |
| 200-Day SMA | 215.91 |
System |
|
| Modified | 2/24/2026 6:54:45 AM EST |